DENTSPLY SIRONA Inc. XRAY is scheduled to release third ... The Zacks Consensus Estimate for EPS implies an improvement of 33.3% from the year-ago figure. ACADIA Pharmaceuticals ACAD has an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback